Interleukin-2 and Alpha Interferon Therapy of Advanced Pulmonary Metastases
作者:
B. Kim,
Patricia Warnaka,
A. Imbembo,
期刊:
European Surgical Research
(Karger Available online 1989)
卷期:
Volume 21,
issue 5
页码: 260-266
ISSN:0014-312X
年代: 1989
DOI:10.1159/000129035
出版商: S. Karger AG
关键词: Interleukin-2;Interferon;Pulmonary metastases
数据来源: Karger
摘要:
Pulmonary metastases of a weakly immunogenic methylcholanthrene-induced murine fibrosarcoma MCA-106 were treated on day 10 for 10 days with saline, interleukin-2 (IL-2), hybrid recombinant interferon A/D (rIFN A/D) or the combination. IL-2/IFN effected > 99% reduction in tumor compared to saline, IL-2 or IFN alone. However, IL-2/IFN also resulted in early ( 150 days). Interruption of the 10-day treatment with a 2-day rest at 5 days abrogated early mortality, but despite significant prolongation of survival, no long-term survivors were seen. These data suggest possible clinical application of IL-2/IFN in the treatment of advanced tumor metastases but cautions of increased treatment toxicity associated with this regimen.
点击下载:
PDF
(901KB)
返 回